Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Biology|August 2, 2006
Casein kinase 2 associates with initiation-competent RNA polymerase I and has multiple roles in ribosomal DNA transcriptionTatiana B Panova, Kostya I Panov, Jackie Russell, et al.
The Journal of Biological Chemistry|June 23, 2005
TBP-TAF complex SL1 directs RNA polymerase I pre-initiation complex formation and stabilizes upstream binding factor at the rDNA promoterJ Karsten Friedrich, Kostya I Panov, Pavel Cabart, et al.
Biotechnology and Bioengineering|September 8, 2004
Adsorption of fluorescein by protein crystalsA Cvetkovic, M Zomerdijk, A J J Straathof, et al.
Drug Safety|September 1, 2023
Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021Sharon C M Essink, Inge M Zomerdijk, Sabine M J M Straus, et al.
Expert Opinion on Drug Safety|August 16, 2018
Measuring the impact of the 2012 European pharmacovigilance legislation on additional risk minimization measuresReynold D C Francisca, Inge M Zomerdijk, Miriam C J M Sturkenboom, et al.
Pharmacoepidemiology and Drug Safety|August 16, 2013
Additional risk minimisation measures in the EU - are they eligible for assessment?Inge M Zomerdijk, Gianluca Trifirò, Fakhredin A Sayed-Tabatabaei, et al.
Drug Safety|April 10, 2025
Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional StudySharon C M Essink, Inge M Zomerdijk, Sabine M J M Straus, et al.
The EMBO Journal|February 24, 2007
A novel TBP-associated factor of SL1 functions in RNA polymerase I transcriptionJulia J Gorski, Shalini Pathak, Kostya Panov, et al.
Clinical Pharmacology and Therapeutics|January 24, 2025
Duration of Time Intervals for Risk Minimization Measure Effectiveness StudiesSharon C M Essink, Inge M Zomerdijk, Thomas Goedecke, et al.
Molecular and Cellular Biology|July 1, 2006
RNA polymerase I-specific subunit CAST/hPAF49 has a role in the activation of transcription by upstream binding factorKostya I Panov, Tatiana B Panova, Olivier Gadal, et al.
Pageof 4